174 related articles for article (PubMed ID: 9872000)
1. Appearance of fosfomycin resistant Rahnella aquatilis clinically isolated in Japan.
O'Hara K; Chen J; Shigenobu F; Nakamura A; Taniguchi K; Shimojima M; Ida H; Yoshikawa E; Tsuboi I; Mizuoka K; Sawai T
Microbios; 1998; 95(381):109-15. PubMed ID: 9872000
[TBL] [Abstract][Full Text] [Related]
2. Mutators among CTX-M beta-lactamase-producing Escherichia coli and risk for the emergence of fosfomycin resistance.
Ellington MJ; Livermore DM; Pitt TL; Hall LM; Woodford N
J Antimicrob Chemother; 2006 Oct; 58(4):848-52. PubMed ID: 16891630
[TBL] [Abstract][Full Text] [Related]
3. Plasmid-determined resistance to fosfomycin in Serratia marcescens.
Mendoza C; Garcia JM; Llaneza J; Mendez FJ; Hardisson C; Ortiz JM
Antimicrob Agents Chemother; 1980 Aug; 18(2):215-9. PubMed ID: 7004337
[TBL] [Abstract][Full Text] [Related]
4. CTX-M-15-producing urinary Escherichia coli O25b-ST131-phylogroup B2 has acquired resistance to fosfomycin.
Oteo J; Orden B; Bautista V; Cuevas O; Arroyo M; Martínez-Ruiz R; Pérez-Vázquez M; Alcaraz M; García-Cobos S; Campos J
J Antimicrob Chemother; 2009 Oct; 64(4):712-7. PubMed ID: 19671590
[TBL] [Abstract][Full Text] [Related]
5. [Prevalence and dispersion of plasmids conferring fosfomycin resistance in enterobacteria].
Hardisson C; Villar CJ; Llaneza J; Mendoza MC
Pathol Biol (Paris); 1984 Sep; 32(7):755-8. PubMed ID: 6387596
[TBL] [Abstract][Full Text] [Related]
6. In vitro investigations on the action fosfomycin alone and in combination with other antibiotics on Pseudomonas aeruginosa and Serratia marcescens.
Ullmann U; Lindemann B
Arzneimittelforschung; 1980; 30(8):1247-9. PubMed ID: 6776966
[TBL] [Abstract][Full Text] [Related]
7. Other antimicrobials of interest in the era of extended-spectrum beta-lactamases: fosfomycin, nitrofurantoin and tigecycline.
Garau J
Clin Microbiol Infect; 2008 Jan; 14 Suppl 1():198-202. PubMed ID: 18154548
[TBL] [Abstract][Full Text] [Related]
8. In vitro activity of fosfomycin against ciprofloxacin-resistant or extended-spectrum beta-lactamase-producing Escherichia coli isolated from urine and blood.
Ko KS; Suh JY; Peck KR; Lee MY; Oh WS; Kwon KT; Jung DS; Lee NY; Song JH
Diagn Microbiol Infect Dis; 2007 May; 58(1):111-5. PubMed ID: 17300900
[TBL] [Abstract][Full Text] [Related]
9. In vitro susceptibility of quinolone-resistant Enterobacteriaceae uropathogens to fosfomycin trometamol, in Dakar, Senegal.
Nabeth P; Perrier-Gros-Claude JD; Juergens-Behr A; Dromigny JA
Scand J Infect Dis; 2005; 37(6-7):497-9. PubMed ID: 16012011
[TBL] [Abstract][Full Text] [Related]
10. Fosfomycin activity versus carbapenem-resistant Enterobacteriaceae and vancomycin-resistant Enterococcus, Detroit, 2008-10.
Pogue JM; Marchaim D; Abreu-Lanfranco O; Sunkara B; Mynatt RP; Zhao JJ; Bheemreddy S; Hayakawa K; Martin ET; Dhar S; Kaye KS; Lephart PR
J Antibiot (Tokyo); 2013 Oct; 66(10):625-7. PubMed ID: 23715037
[No Abstract] [Full Text] [Related]
11. [Short communication: comparison of susceptibilities of Escherichia coli urinary tract isolates against fosfomycin tromethamine and different antibiotics].
Aykut Arca E; Karabiber N
Mikrobiyol Bul; 2007 Jan; 41(1):115-9. PubMed ID: 17427560
[TBL] [Abstract][Full Text] [Related]
12. Fosfomycin tromethamine as second agent for the treatment of acute, uncomplicated urinary tract infections in adult female patients in The Netherlands?
Knottnerus BJ; Nys S; Ter Riet G; Donker G; Geerlings SE; Stobberingh E
J Antimicrob Chemother; 2008 Aug; 62(2):356-9. PubMed ID: 18424789
[TBL] [Abstract][Full Text] [Related]
13. [Biological cost associated with fosfomycin resistance in Escherichia coli isolates from urinary tract infections].
Alós JI; García-Peña P; Tamayo J
Rev Esp Quimioter; 2007 Jun; 20(2):211-5. PubMed ID: 17893758
[TBL] [Abstract][Full Text] [Related]
14. Antibacterial susceptibility of enterobacteriaceae isolated from raw horsemeat isolated for human consumption (basashi).
Furuhata K; Ishizaki N; Fukuyama M
Biocontrol Sci; 2015; 20(1):19-25. PubMed ID: 25817809
[TBL] [Abstract][Full Text] [Related]
15. Occurrence and antibiotic sensitivity of Enterobacteriaceae isolated from a group of Jordanian patients with community acquired urinary tract infections.
Abu Shaqra Q
Cytobios; 2000; 101(396):15-21. PubMed ID: 10697742
[TBL] [Abstract][Full Text] [Related]
16. Antibiotic-resistant Serratia marcescens infection in a hospital.
Ambrosio RE; Van Wyk AJ; De Klerk HC
S Afr Med J; 1979 Apr; 55(15):584-7. PubMed ID: 380020
[TBL] [Abstract][Full Text] [Related]
17. [Statistical observation of urinary tract infections by Serratia marcescens].
Kamiryo Y; Sakatoku J
Hinyokika Kiyo; 1983 Apr; 29(4):401-10. PubMed ID: 6203384
[TBL] [Abstract][Full Text] [Related]
18. Natural antibiotic susceptibility of Rahnella aquatilis and R. aquatilis-related strains.
Stock I; Grüger T; Wiedemann B
J Chemother; 2000 Feb; 12(1):30-9. PubMed ID: 10768513
[TBL] [Abstract][Full Text] [Related]
19. Fosfomycin and plasmidic resistance.
Baquero F; López-Brea M; Valls A; Cañedo T
Chemotherapy; 1977; 23 Suppl 1():133-40. PubMed ID: 318973
[TBL] [Abstract][Full Text] [Related]
20. Antibiotic susceptibility patterns surveillance and clinical distribution of Enterobacteriaceae.
Garbagnoli P; Pagani L
Microbiologica; 1992 Apr; 15(2):135-47. PubMed ID: 1602984
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
